DiscoveRx is a fast growing innovative company that develops, manufactures, and commercializes reagents and complete assay kits for the drug discovery and screening markets. Our products, which include both in vitro biochemical assays and cell-based assays, enable customers to improve research productivity and effectiveness, thus accelerating the discovery and development of new drugs.
Kathyrn Woods‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.
|Status:||No. Reviews Published:|
To be seen as an authority on SelectScience, find your products to review today., Pfizer
The KINOMEscan screening platform employs a novel and proprietary active site-directed competition binding assay to quantitatively measure interact...
More about the KINOMEscan™ Binding Assays
PathHunter® Activated GPCR Internalization Assays provide a quantitative measurement of internalized GPCR protein localized to the endocytic compa...
More about the PathHunter® Activated GPCR Endocytosis Assays
PathHunter® Total GPCR Endocytosis Assay provides a quantitative measurement of total GPCR protein whether it is localized to the cell surface or in...
More about the PathHunter® Total GPCR Endocytosis Assay
PathHunter™ Nuclear Translocation Assays are single-addition, homogeneous assays that measure the effects of agonist or antagonist compounds on targe...
More about the PathHunter™ Nuclear Translocation Assays
DiscoveRx to Launch PathHunter™ GPCR Explorer Kit for Building On-Demand Functional GPCR Assays at MipTec 2010
15 Sep 2010
22 Jan 2010
DiscoveRx Signs a Worldwide Agreement with GlaxoSmithKline (GSK) that Allows GSK Access to PathHunter™ ß-Arrestin Cell lines and Reagents for G-PCR Screening
29 Oct 2009
12 Sep 2008
08 May 2007
Automating a Direct, Cell-Based, Target-Compound Interaction Assay for G9a Histone Methyltransferase and Bromodomain ProteinsDiscoveRx Corporation
16 Apr 2013
InCELL Hunter: A Novel Cellular Assay Platform for the Direct Measurement of Compound Binding to Epigenetic and Kinase Targets in Intact Mammalian CellsDiscoveRx Corporation
24 Sep 2012
- DiscoveRx Corporation
07 Mar 2012
- DiscoveRx Corporation
29 Jun 2011
Rapid Quantification of Bioactive Ligands in Serum and Human Plasma Using PathHunter eXpress β-Arrestin GPCR AssaysDiscoveRx Corporation
18 May 2011